Free Republic 2nd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $21,133
26%  
Woo hoo!! And we're now over 26%!! Thank you all very much!! God bless.

Keyword: braf

Brevity: Headers | « Text »
  • Supporters rally in Raleigh for jailed immigrant

    03/11/2012 9:17:29 AM PDT · by moonshinner_09 · 19 replies
    The News & Observer ^ | Mar 11, 2012 | RON GALLAGHER
    RALEIGH -- With posters and candles, about 30 people held a vigil Friday night outside the Wake County jail to support a man who was arrested Feb. 29 during a protest at a legislative committee hearing and is now being held for federal immigration authorities. Uriel Alberto was one of three people charged with disorderly conduct after a demonstration near the conclusion of a state House committee hearing on immigration policy. Wearing T-shirts that said "Undocumented and Unafraid," they began shouting after Republican state Rep. George Cleveland suggested illegal immigrants who come as workers bring crime to the state. Taken...
  • Target Cancer - A Roller Coaster Chase for a Cure

    02/25/2010 1:25:50 PM PST · by neverdem · 17 replies · 476+ views
    NY Times ^ | February 22, 2010 | AMY HARMON
    PHILADELPHIA — His patient, a spunky Italian-American woman in her 60s, was waiting in an exam room down the hall for the answer: Was the experimental drug stopping her deadly skin cancer? But as Dr. Keith Flaherty read out the measurements of her tumors from the latest CT scan, he could not keep the distress from his voice. “She’s worse,” he said to the clinical trial nurse at the University of Pennsylvania’s melanoma clinic. Like the 17 other patients on the drug trial — the corporate lawyer, the receptionist with young children, the Philadelphia philanthropist — the woman known in...
  • Target Cancer - A Drug Trial Cycle: Recovery, Relapse, Reinvention

    02/24/2010 10:11:48 PM PST · by neverdem · 10 replies · 658+ views
    NY Times ^ | February 24, 2010 | AMY HARMON
    ORLANDO, Fla. — On a sunny afternoon last June, Dr. Keith Flaherty stood before a large room packed with oncologists from around the world and described the extraordinary recovery of the melanoma patients in the experimental drug trial he was leading. It was a moment he had looked forward to for months. Beyond a breakthrough for melanoma, the results were a promising sign for an approach to treatment for all forms of cancer that he and others had championed as more effective and less toxic than standard chemotherapy. But even as he flashed the slide of his favorite graph, showing...